CSS »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by CSS

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by CSS from 13F filings

Historical chart of CSS investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by CSS consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by CSS

Quarter filed Position value Share count Share price at filing
2026-03-31 $24M 19M 1.29
2024-06-30 $2.7M 2.5M 1.08
2023-12-31 $2.3M 2.4M 0.99

More positions owned by CSS

Lumentum Hldgs Note 0.500% 6/1 (Principal)
Echostar Corp Note 3.875%11/3 (Principal)
Jazz Investments I Note 2.000% 6/1 (Principal)
Live Nation Entertainment In Note 3.125% 1/1 (Principal)
Transocean Deb 4.625% 9/3 (Principal)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Gamestop Corp Cl A (GME)
Nextera Energy Unit 02/15/2029 (NEE.PV)
Centerpoint Energy Note 4.250% 8/1 (Principal)
Penumbra (PEN)
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)
Hologic
Spdr Gold Tr Gold Shs (GLD)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for CSS

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Steelhead Partners
Bnp Paribas Arbitrage, Snc
Alberta Investment Management Corporation
DeepCurrents Investment Group
State Street Corporation
FMR
CSS
BlackRock
MacKay Shields
Manufacturers Life Insurance Company
Bank of America Corporation
Universal- Beteiligungs- und Servicegesellschaft mbH
Two Sigma Investments
Citigroup
Warberg Asset Management

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1